Cynthia Patton - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Senior Vice President Chief Compliance Officer

Ms. Cynthia M. Patton is the Senior Vice President, Chief Compliance Officer of Amgen Inc
Age: 54  President Since 2012      
Patton joined the Company in 2005. From July 2005 to September 2010, Ms. Patton was Associate General Counsel. From September 2010 to October 2012, Ms. Patton was Vice President, Law. Previously, Ms. Patton served as Senior Vice President, General Counsel and Secretary of SCAN Health Plan from 1999 to 2005.

Cynthia Patton Latest Insider Activity

Cynthia Patton over two weeks ago via Macroaxis 
Payment of 132 shares by Cynthia Patton of Amgen subject to Rule 16b-3
Cynthia Patton over two months ago via Macroaxis 
Amgen exotic insider transaction detected
Cynthia Patton over six months ago via Macroaxis 
Amgen exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


JeanYves PaveeAbbott Laboratories
Brian LortieEndo International plc
Michael RousseauAbbott Laboratories
Robert FunckAbbott Laboratories
Philippe SchaisonAllergan plc
Daniel SalvadoriAbbott Laboratories
Robert FordAbbott Laboratories
William MeuryAllergan plc
Blaise ColemanEndo International plc
Wayne SwantonAllergan plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Eric FainAbbott Laboratories
Jared WatkinAbbott Laboratories
Terrance CoughlinEndo International plc
Michael PartridgeVertex Pharmaceuticals Incorpor
Scott WhiteAbbott Laboratories
Camille FarhatEndo International plc
Michael WarmuthAbbott Laboratories
Roger BirdAbbott Laboratories
Shawn SoderbergBio Rad Laboratories Inc
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Balance Of Power Now

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Hide  View All  NextLaunch Balance Of Power
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators